Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2018

Feb 9, 2018

33899_dirs_2018-02-09_39490e15-0a3a-48de-a97a-429c1d05df7b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2017-12-31

Reporting Person: MACDONALD MICHAEL C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-31 Common Stock F 15200 $69.81 Disposed 352908 Direct
2018-02-07 Common Stock A 1280 Acquired 354188 Direct

Footnotes

F1: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2019.